Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal.
Davì MV, Bodei L, Ferdeghini M, Falconi M, Testoni M, Paganelli G, Oliani C, Lo Cascio V, Francia G. Davì MV, et al. Among authors: ferdeghini m. Endocr Pract. 2008 Mar;14(2):213-8. doi: 10.4158/EP.14.2.213. Endocr Pract. 2008. PMID: 18308661
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal.
Frigo A, Dardano A, Danese E, Davì MV, Moghetti P, Colato C, Francia G, Bernardi F, Traino C, Monzani F, Ferdeghini M. Frigo A, et al. Among authors: ferdeghini m. J Clin Endocrinol Metab. 2009 Sep;94(9):3472-6. doi: 10.1210/jc.2008-2830. Epub 2009 Jun 9. J Clin Endocrinol Metab. 2009. PMID: 19509107 Clinical Trial.
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A, Claudio Traino A, Boni G, Grosso M, Lazzeri P, Colato C, Davì MV, Francia G, Lazzeri M, Mariani G, Ferdeghini M. Vaiano A, et al. Among authors: ferdeghini m. Nucl Med Commun. 2007 Mar;28(3):215-23. doi: 10.1097/MNM.0b013e328014a0f6. Nucl Med Commun. 2007. PMID: 17264781 Clinical Trial.
172 results